Clinical Trials on Clinical Deterioration in Mexico

Total 36 results

Instituto Mexicano del Seguro Social

Completed

Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure (SODA-HF)

Heart Failure, Systolic | Clinical Trial | Natriuretic Peptide, Brain | Diet, Sodium-Restricted

Mexico
University of New Mexico
National Center for Research Resources (NCRR)

Terminated

Commerical DHA Supplementation

Pregnancy | Randomized Clinical Trial | Docosahexaenoic Acid

United States
University of California, San Diego
National Institute of Mental Health (NIMH)

Unknown

Compensatory Cognitive Training in Clinical High Risk Latino Youth

Schizophrenia | Psychosis | Clinical High Risk | Prodromal

United States, Mexico
InLight Solutions
Luminous Medical

Completed

Near Infrared Spectroscopy for Blood Glucose Measurement in Critical Care Settings

Critical Care

United States
Zimmer Biomet

Active, not recruiting

Prospective G7 Dual Mobility Total Hip PMCF

Clinical Outcomes | Survivorship | Safety | Functional Outcomes | Radiological Outcomes

United States
Hospital Civil de Guadalajara
Instituto Jalisciense de Cancerologia

Recruiting

The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients (INVADE)

Critical Illness

Mexico
University of New Mexico
National Institute of Mental Health (NIMH)

Completed

Feasibility of an Early Detection Program for Early Psychosis on a College Campus

Psychosis | Clinical High Risk for Psychosis | First Episode Psychosis

United States
Centro de Investigación en Alimentación y Desarrollo...

Completed

Dietary Intervention to Reduce Metabolic Endotoxemia

Obesity | Endotoxemia | Dietary Habits | Clinical Trial | Intestinal Microbiota

Mexico
Grupo Mexicano para el Estudio de la Medicina Intensiva

Completed

Ultrasound Meal Accommodation Test for Enteral Feeding in the Critically Ill (UMATI)

Enteral Feeding Intolerance

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients (SPIROCAN)

Cancer | Critically Ill

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Phase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Mexico
Federico II University

Not yet recruiting

LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries (LEGDEB2)

Arterial Occlusive Diseases | Peripheral Arterial Disease | Popliteal Artery Stenosis | Critical Limb Ischemia | Superficial Femoral Artery Stenosis | Iliac Artery Stenosis

Italy, Mexico
University of Iowa

Active, not recruiting

Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT

Acute Kidney Injury | Critical Illness Myopathy | Dialysis; Complications

United States
Hospital Juarez de Mexico

Completed

Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema

Diabetic Retinopathy | Clinically Significant Macular Edema

Mexico
National Cancer Institute (NCI)

Suspended

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Esophageal Adenocarcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma... and other conditions

United States
LimFlow, Inc.

Completed

PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System

Critical Limb Ischemia

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditions

United States, Puerto Rico
Clinical Evaluation Research Unit at Kingston General...

Completed

The Effect of Higher Protein Dosing in Critically Ill Patients (EFFORT)

Critical Illness | Malnutrition

United Kingdom, United States, Canada, Saudi Arabia, Malaysia, Argentina, Australia, Brazil, Greece, Hong Kong, India, Iran, Islamic Republic of, Japan, Mexico, Panama, Puerto Rico
Duke University
Johns Hopkins University; National Institutes of Health (NIH); Vanderbilt University... and other collaborators

Terminated

DOSE Trial of Opioid Sparing Effect (DOSE)

Critically Ill | Dexmedetomidine | Mechanical Ventilation Complication

United States
C. R. Bard
Bard Ltd

Completed

Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Critical Limb Ischemia

United States, Japan, Austria, Canada, Switzerland, Italy, Belgium, Germany
Mayo Clinic

Completed

The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)

Sepsis | Shock | Critical Illness | Respiratory Failure | Bleeding | Trauma | Coma

China, Brazil, Belarus, Serbia, India, Turkey, Bosnia and Herzegovina, Croatia, Dominican Republic, Ireland, Mexico, Mongolia, Pakistan, Philippines, Poland, Saudi Arabia, Uganda
LimFlow, Inc.

Active, not recruiting

PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (PROMISE)

Vascular Diseases | Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia | Arterial Disease | Arterial Occlusion | Critical Lower Limb Ischemia | Chronic Limb-Threatening Ischemia | Peripheral Artery Occlusion | Peripheral...

United States, Puerto Rico
National Cancer Institute (NCI)

Active, not recruiting

A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma

Clinical Stage III Cutaneous Melanoma AJCC v8 | Mucosal Melanoma | Acral Lentiginous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma

Unresectable Cutaneous Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Mucosal Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8

United States
National Cancer Institute (NCI)

Active, not recruiting

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

Metastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8

United States
LimFlow, Inc.

Recruiting

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Peripheral Arterial Disease | Critical Limb Ischemia | Chronic Limb-Threatening Ischemia

United States
HealthCore-NERI
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Completed

Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST-CLI)

Critical Limb Ischemia

United States, Canada, New Zealand, Finland, Italy
National Cancer Institute (NCI)

Recruiting

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage III HPV-Mediated (p16-Positive)...

United States
National Cancer Institute (NCI)

Active, not recruiting

High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Metastatic Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recurrent Mucosal Melanoma | Metastatic Mucosal Melanoma | Non-Cutaneous Melanoma | Metastatic Non-Cutaneous Melanoma | Recurrent Non-Cutaneous...

United States, Canada, Ireland
Boston Scientific Corporation

Active, not recruiting

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia (SAVAL)

Critical Limb Ischemia

United States, France, Japan, Belgium, Netherlands
Ictal Group

Unknown

Acute Encephalopathy in Critically Ill Patients With COVID-19 (NeuroCOVID19)

COVID-19 | Critically Ill | Encephalopathy

Egypt, France, United States, Brazil, Colombia, Mexico, Spain
National Cancer Institute (NCI)

Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Melanoma | Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage IV HPV-Mediated... and other conditions

United States
National Cancer Institute (NCI)
NRG Oncology

Suspended

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Oropharyngeal Squamous Cell Carcinoma | Squamous Cell Carcinoma | Basaloid Squamous Cell Carcinoma | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Papillary Squamous Cell Carcinoma | Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC... and other conditions

United States, Canada
University of Michigan
Medical University of South Carolina; National Institute of Neurological Disorders... and other collaborators

Recruiting

Sleep for Stroke Management and Recovery Trial (Sleep SMART)

Stroke | Sleep Apnea, Obstructive | Ischemic Stroke | Sleep Apnea | Telemedicine | TIA | Randomized Clinical Trial | CPAP | Home Sleep Apnea Test | Multicenter Trial

United States
National Cancer Institute (NCI)

Recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IV Hypopharyngeal... and other conditions

United States
National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage... and other conditions

United States, Canada

Clinical Trials on Clinical Deterioration in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations